Jiu Dian Pharmaceutical: In the first half of 2022, revenue achieved 1.031 billion yuan, an increase of 40.89% year -on -year

On July 29, 2022, the A -share listed company Jiu Dian Pharmaceutical (Code: 300705.SZ) released the 2022 semi -annual performance report.

From January 1, 2022-June 30, 2022, the company realized operating income of 1.031 billion yuan, an increase of 40.89%year-on-year, and net profit was 130 million yuan, an increase of 15.02%year-on-year, and the basic earnings per share were 0.39 yuan.

The company's industry is chemical pharmaceutical.

During the company's reporting period, the total assets at the end of the period were 1.805 billion yuan, the operating profit was 146 million yuan, the accounts receivable were 356 million yuan, and the net cash flow generated by operating activities was 39.143 million yuan.Cash is 1050 million yuan.

Jiu Dian Pharmaceutical, the company's full name of Hunan Jiudian Pharmaceutical Co., Ltd., was established on January 19, 2001. The current general manager Zheng Xiahui, the main business is the research and development, production and sales of pharmaceutical products.

- END -